Hunan Issues 15th Five-Year Plan for Traditional Chinese Medicine Development

The significance here lies less in TCM promotion than in the financing mechanism: bringing commercial insurers into preventive TCM treatment shifts part of the cost burden away from public health insurance and toward private products, a model worth monitoring as provincial plans proliferate. The explicit link between price adjustments and proven efficacy also signals a push to tie provider revenue to outcomes rather than volume. Whether commercial TCM products gain real traction, and how efficacy gets defined for pricing purposes, are the open questions.